Lincoln Pharmaceuticals Ltd Q4 FY2023-2024 Results: Summary
Revenue | ₹149.51Cr |
Net Profits | ₹18.60Cr |
Net Profit Margins | 12.44% |
Highlights
Revenue:
Lincoln Pharmaceuticals Ltd’s revenue jumped 28.49% since last year same period to ₹149.51Cr in the Q4 2023-2024. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -5.05% fall in its revenue since last 3-months.
Net Profits:
Lincoln Pharmaceuticals Ltd’s net profit jumped 48.09% since last year same period to ₹18.60Cr in the Q4 2023-2024. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -33.67% fall in its net profits since last 3-months.
Net Profit Margins:
Lincoln Pharmaceuticals Ltd’s net profit margin jumped 15.25% since last year same period to 12.44% in the Q4 2023-2024. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated -30.13% fall in its net profit margins since last 3-months.
